Pharmacists on the Multidisciplinary Team: Implementing Best Practices in Chemo-Induced Nausea and Vomiting (CINV) Management
This Continuing Education activity is supported by educational grants from Eisai Inc., Merck Sharp & Dohme Corp., and Tesaro, Inc.
This activity is supported by educational grants from Eisai Inc., Merck Sharp & Dohme Corp., and Tesaro, Inc.
Faculty
Sally Yowell Barbour, PharmD, BCOP, CPP
Director of Oncology Pharmacy Programs
Duke University Hospital
Durham, North Carolina
Chicago, Illinois
Editorial Support
Jeannette Y. Wick, RPh, MBA, FASCP
Freelance Medical Writer
Arlington, Virginia
Visiting Professor
University of Connecticut School of Pharmacy
Storrs, Connecticut
Educational Objectives
After completing this continuing education program, the participant will be able to:
- Identify guideline-consistent care that recommends antiemetic regimens for chemo-induced nausea and vomiting (CINV)
- Explain safety and efficacy profiles for established regimens and new antiemetic strategies for CINV
- Illustrate strategies for managing challenging situations such as breakthrough symptoms, delayed CINV, managing nausea, and providing antiemetic regimens for multiday chemotherapy
- Examine a multidisciplinary approach to patient education, communication, and ongoing assessment that is most likely to improve outcomes in CINV
Target audience: Pharmacists, health system pharmacists, specialty pharmacists
Type of activity: Application
Release date: September 8, 2016
Expiration date: September 8, 2017
Estimated time to complete activity: 2.0 hours
Fee: Free
Pharmacy Times Continuing Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.20 CEUs) under the ACPE universal activity number 0290-0000-16-120-H01-P. The activity is available for CE credit through September 8, 2017.
Articles in this issue
almost 9 years ago
Article
Pharmacogenetic Resources: PharmGKB and Clinical Pharmacogenetics Implementation ConsortiumNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025
- Evaluation of Pharmacist-Driven Penicillin Allergy Reconciliation
September 17th 2025
- Pharmacists Can Apply Their Expertise to the Medical Psilocybin Act
September 16th 2025
- From Curiosity to Clinical Impact: Shremo Msdi’s Path in Pharmacy Research
September 15th 2025